| Previous Close | 32.89 |
| Open | 32.79 |
| Bid | 0.00 x |
| Ask | 0.00 x |
| Day's Range | 32.69 - 33.00 |
| 52 Week Range | 29.83 - 37.39 |
| Volume | 16,661,472 |
| Avg. Volume | 20,276,650 |
| Market Cap | 196.94B |
| Beta | 1.07 |
| PE Ratio (TTM) | 27.78 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | 1.28 (3.87%) |
| Ex-Dividend Date | 2017-08-02 |
| 1y Target Est | N/A |
- Motley Fool•18 minutes ago
Mighty AstraZeneca Takes a Lickin' on Failed Mystic Trial
AstraZeneca's attempts to challenge competitors for dominance in treating non-small lung cancer were dashed today when data from a key trial came up short.
- The Wall Street Journal•1 hour ago
[$$] United Therapeutics in Settlement Talks With Justice Department
United Therapeutics has set aside $210 million for a possible settlement of a U.S. Justice Department investigation of whether the company’s contributions to patient-assistance charity groups violate federal ...
- Financial Times•9 hours ago
[$$] AstraZeneca: transcendental agitation
Philosopher Blaise Pascal never faced proof he was wrong to believe in God. AstraZeneca's Pascal Soriot has discovered his faith in the Mystic cancer drug trial really was misplaced. A failure of a key ...
